Follow the HLB stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, HLB has recorded 52 reports. Market capitalisation: €6,125.6bn. The latest transaction was reported on 9 June 2026 (Other). Among the most active insiders: 진양곤. The full history is free.
52
Insider Decl.
0
Thresholds
·
22 ops.
Buy Volume
·
1 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,442 of 25,484 companies
27.4
score / 100
Value
27
Quality
28
FCF yld-1.7%
Earn yld-3.4%
EV/EBITDA·
ROE-38%
Gross mgn33%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.